Secondary primary malignancy presence and related factors in chronic lymphocytic leukemia

Journal Title: Medical Science and Discovery - Year 2018, Vol 5, Issue 1

Abstract

Objective: The secondary primary malignancy frequencies have seen increased in chronic lymphocytic leukemia (CLL) regardless of therapy. The aim of this study was to investigate the frequency of secondary primary malignancy in patients followed with the diagnosis of chronic lymphocytic leukemia. Materials and Methods: The 183 patients with diagnosed of CLL were enrolled into this study. The data of the patients were evaluated retrospectively. Patients diagnosed with CLL were categorized according to age, gender and presence or absence of additional malignancy. Patients with CLL and concomitant malignancy were compared with other patients. Results: Fifty four patients (29.5%) were female and 129 (70.5%) were male. Secondary primary malignancy was detected in 9 (%4,9) patients. CD5 positivity was found in all of the patients with malignancy and in 91% of whole patients. 5.4% of males and 3.7% of females had solid organ tumors with CLL. Although the proportion of solid tumors was higher in males, this difference was not statistically significant (p = 0.847). The mean age of cases with secondary malignancy was statistically significantly higher than that without secondary malignancy (p <0.05). Conclusion:  In our study, all of the patients with the second primary malignancy were CD5 positive. BCL2 proto-oncogene levels were found increased in CD5-positive CLL cells, not in normal B cells those were positive for CD5. In vitro studies showed that, B-CLL cells with higher BCL2 levels survive is longer than cells with lower BCL2 levels. Presence of the secondary malignancy except CLL may be related with BCL2 increment as well as CD5 positivity. We need more comprehensive studies to determine the relationship between the presence of BCL2, CD5 positivity and  secondary malignancies.

Authors and Affiliations

Omer Ekinci, Ali Dogan, Sinan Demircioglu, Ergin Turgut, Cengiz Demir

Keywords

Related Articles

A case of intracranial migration and rapid spontaneous resolution of traumatic acute subdural hematoma

Traumatic acute subdural hematoma (ASDH) is one of the most destructive forms of traumatic brain injury (TBI), involving estimated mortality rates of 40-60% . Traumatic ASDH is a frequently seen life-threatening conditio...

The effect of gel foam mattress use during total hip replacement surgeries on the development of pressure ulcers in the recovery unit: a quasi-experimental study

Objective:  This study was conducted on patients undergoing total hip replacements in order to examine the effect of the use of a gel foam mattress during surgery on preventing the development of pressure ulce...

A possible alternate pathway for intravascular thrombosis - Investigation of the circumstantial evidence by microfluidics

In light of the literature, in this hypothesis, we aimed to settle up an experimental procedure and possible mechanism for bacteremia induced disseminated intravascular coagulation via QA. Bacteremia resulting in sepsis...

Effect of Acetaminofen Versus Lornoxicam Admistration on Oxidative Stress in Rat Hepatic and Renal Tissues

Background and aim: The aim of study was to assess the oxidative status in rat hepatic and renal tissues after intraperitoneal administration of acetaminophen (AP) versus lornoxicam (L).Materials and Methods: For this pu...

The effects of application of 0.5% levobupivacaine together with 5 mg dexamethasone for infra-clavicular block in surgical treatment of forearm fractures

Objective:  We aimed to investigate the effects of adding 5mg dexamethasone to 0.5% levobupivacaine on postoperative analgesia after US-guided infra-clavicular block. Methods: This prospective study was perf...

Download PDF file
  • EP ID EP520718
  • DOI 10.17546/msd.378567
  • Views 39
  • Downloads 0

How To Cite

Omer Ekinci, Ali Dogan, Sinan Demircioglu, Ergin Turgut, Cengiz Demir (2018). Secondary primary malignancy presence and related factors in chronic lymphocytic leukemia. Medical Science and Discovery, 5(1), 106-109. https://europub.co.uk/articles/-A-520718